Insider transactions

EDGAR

X4 PHARMACEUTICALS, INC

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
1 transactions, 4,600 shares
Sum of shares × price per share: 11,883.64
Open-market sales (code S)
5 transactions, 109,283 shares
Sum of shares × price per share: 462,964.2245

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–11 of 11

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-16 Filed 2026-10-19Craig Adam R Director · Officer: Executive Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)4,6002.5834
11,883.64

Derived: shares × price per share. Exact value 11883.6400.

333,251Direct (D) No
F1, F2
  • F1 Of the shares of common stock reported, 193,254 shares represent restricted stock units.
  • F2 The Reporting Person has agreed to disgorge to the Issuer all profits deemed to be realized from this transaction pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.
Open filing 0001339498-26-000005 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-05KIRSKE DAVID Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)11,7672.8604
33,658.3268

Derived: shares × price per share. Exact value 33658.3268.

155,983Direct (D) No
F1, F2, F3
  • F1 Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $2.82 to $2.92, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Of the shares of common stock reported, 64,418 shares represent restricted stock units.
Open filing 0001501697-26-000078 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-13Craig Adam R Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)47,4364.4445
210,829.302

Derived: shares × price per share. Exact value 210829.3020.

328,651Direct (D) No
F1, F2, F3
  • F1 Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.33 to $4.55, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Of the shares of common stock reported, 193,254 shares represent restricted stock units.
Open filing 0001501697-26-000069 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-13Volpone John Officer: President
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)24,5764.4445
109,228.032

Derived: shares × price per share. Exact value 109228.0320.

265,305Direct (D) No
F1, F2, F3
  • F1 Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.33 to $4.55, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Of the shares of common stock reported, 193,254 shares represent restricted stock units.
Open filing 0001501697-26-000070 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-01Gold Kelly Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (110,000) — exercise price 4.085
Acquired (A)110,0000—110,000Direct (D) No
F1
  • F1 The shares subject to the option shall vest in full on the one-year anniversary of the grant date, subject to the Reporting Person continuing to provide services through such date.
Open filing 0001501697-26-000064 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01KIRSKE DAVID Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,5434.2641
36,428.2063

Derived: shares × price per share. Exact value 36428.2063.

167,750Direct (D) No
F1, F2, F3
  • F1 Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.21 to $4.31, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Of the shares of common stock reported, 96,627 shares represent restricted stock units.
Open filing 0001501697-26-000065 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-13KIRSKE DAVID Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)16,9614.2934
72,820.3574

Derived: shares × price per share. Exact value 72820.3574.

176,293Direct (D) No
F1, F2, F3
  • F1 Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.20 to $4.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Of the shares of common stock reported, 128,836 shares represent restricted stock units.
Open filing 0001501697-26-000049 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-07Bridger Gary Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (110,000) — exercise price 4
Acquired (A)110,0000—0Direct (D) No
F1
  • F1 The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date.
Open filing 0001501697-26-000009 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05WYZGA MICHAEL S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (110,000) — exercise price 4
Acquired (A)110,0000—0Direct (D) No
F1
  • F1 The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date.
Open filing 0001501697-26-000006 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05Stewart Murray Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (110,000) — exercise price 4
Acquired (A)110,0000—0Direct (D) No
F1
  • F1 The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date.
Open filing 0001501697-26-000005 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05de Craecker Francoise Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (110,000) — exercise price 4
Acquired (A)110,0000—0Direct (D) No
F1
  • F1 The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date.
Open filing 0001501697-26-000007 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 100

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
MORGAN STANLEY Partly reported under another manager10,996,210 SH31,889,010 dollarsHigher by 1,534,931 Prior quarter: 9,461,279Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Empery Asset Management, LP 9,725,509 SH28,203,976 dollarsHigher by 2,794,918 Prior quarter: 6,930,591Open filing 0000919574-26-008014 Filed 2026-11-16 Dispute this row
Bain Capital Life Sciences Investors, LLC 7,967,454 SH23,105,616 dollarsUnchanged Prior quarter: 7,967,454Open filing 0001193125-26-462089 Filed 2026-11-16 Dispute this row
Venrock Adviser, LLC 7,644,072 SH22,167,809 dollarsHigher by 5,709,819 Prior quarter: 1,934,253Open filing 0001615982-26-000019 Filed 2026-11-16 Dispute this row
Saturn V Capital Management LP 7,366,442 SH21,362,682 dollarsHigher by 393,099 Prior quarter: 6,973,343Open filing 0001964437-26-000015 Filed 2026-11-16 Dispute this row
PERCEPTIVE ADVISORS LLC 7,350,491 SH21,316,424 dollarsLower by 583,000 Prior quarter: 7,933,491Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager5,854,521 SH16,978,112 dollarsHigher by 299,615 Prior quarter: 5,554,906Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager5,490,787 SH15,923,283 dollarsLower by 2,830,870 Prior quarter: 8,321,657Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Deep Track Capital, LP 4,501,684 SH13,054,884 dollarsLower by 1,377,073 Prior quarter: 5,878,757Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row
Kalehua Capital Management LLC 3,722,840 SH10,796,236 dollarsLower by 3,722,840 Prior quarter: 7,445,680Open filing 0002106181-26-000010 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,558,591 SH10,319,914 dollarsLower by 157,268 Prior quarter: 3,715,859Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Rosalind Advisors, Inc. 3,214,766 SH9,322,821 dollarsUnchanged Prior quarter: 3,214,766Open filing 0001622627-26-000034 Filed 2026-11-16 Dispute this row
Trails Edge Capital Partners, LP 2,571,478 SH7,457,287 dollarsUnchanged Prior quarter: 2,571,478Open filing 0002077247-26-000005 Filed 2026-11-16 Dispute this row
Nantahala Capital Management, LLC 2,449,468 SH7,103,457 dollarsLower by 2,449,468 Prior quarter: 4,898,936Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row
Blackstone Inc. Partly reported under another manager2,427,080 SH7,038,532 dollarsLower by 254,842 Prior quarter: 2,681,922Open filing 0001193125-26-463513 Filed 2026-11-16 Dispute this row
BRAIDWELL LP 2,344,822 SH6,799,984 dollarsLower by 577,932 Prior quarter: 2,922,754Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager2,335,042 SH6,771,622 dollarsHigher by 1,418,506 Prior quarter: 916,536Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Affinity Asset Advisors, LLC 2,062,500 SH5,981,250 dollarsHigher by 1,917,500 Prior quarter: 145,000Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager2,047,281 SH5,938,800 dollarsLower by 50,766 Prior quarter: 2,098,047Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
STATE STREET CORP Partly reported under another manager1,730,123 SH5,017,357 dollarsHigher by 434,106 Prior quarter: 1,296,017Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
BVF INC/IL Partly reported under another manager1,576,624 SH4,572,210 dollarsLower by 657,118 Prior quarter: 2,233,742Open filing 0000921895-26-003162 Filed 2026-11-16 Dispute this row
SAMSARA BIOCAPITAL, LLC 1,347,723 SH3,908,397 dollarsLower by 47,864 Prior quarter: 1,395,587Open filing 0001744967-26-000014 Filed 2026-11-16 Dispute this row
Woodline Partners LP 1,001,095 SH2,903,176 dollarsUnchanged Prior quarter: 1,001,095Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager627,744 SH1,820,458 dollarsLower by 25,105 Prior quarter: 652,849Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 572,106 SH1,659,107 dollarsHigher by 29,978 Prior quarter: 542,128Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 512,811 SH1,487,152 dollarsLower by 59,227 Prior quarter: 572,038Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Verdad Advisers, LP 323,166 SH937,181 dollarsLower by 28,927 Prior quarter: 352,093Open filing 0001420506-26-002833 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager289,231 SH838,770 dollarsHigher by 237,431 Prior quarter: 51,800Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 263,282 SH763,518 dollarsHigher by 18 Prior quarter: 263,264Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Caption Management, LLC Option: Call 250,000 SH725,000 dollarsUnchanged Prior quarter: 250,000Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row
Integral Health Asset Management, LLC 250,000 SH725,000 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005192 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager241,500 SH700,350 dollarsLower by 8,800 Prior quarter: 250,300Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager227,472 SH659,668 dollarsHigher by 152,677 Prior quarter: 74,795Open filing 0000748054-26-000009 Filed 2026-11-20 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager213,258 SH618,447 dollarsHigher by 206,080 Prior quarter: 7,178Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager204,991 SH594,474 dollarsHigher by 8,651 Prior quarter: 196,340Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager150,205 SH435,595 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Stonepine Capital Management, LLC 150,000 SH435,000 dollarsLower by 74,989 Prior quarter: 224,989Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row
ALPS ADVISORS INC 130,424 SH378,230 dollarsHigher by 34,698 Prior quarter: 95,726Open filing 0001398344-26-019318 Filed 2026-11-03 Dispute this row
Invesco Ltd. Partly reported under another manager117,230 SH339,967 dollarsHigher by 20,458 Prior quarter: 96,772Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager115,524 SH335,020 dollarsHigher by 97,424 Prior quarter: 18,100Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Nuveen, LLC Partly reported under another manager111,057 SH322,065 dollarsHigher by 3,668 Prior quarter: 107,389Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
PRUDENTIAL FINANCIAL INC Partly reported under another manager109,705 SH318,145 dollarsHigher by 97,205 Prior quarter: 12,500Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row
Susquehanna Portfolio Strategies, LLC 102,223 SH296,447 dollarsHigher by 14,941 Prior quarter: 87,282Open filing 0001996449-26-000009 Filed 2026-11-16 Dispute this row
XTX Topco Ltd Partly reported under another manager100,745 SH292,161 dollarsNot in the prior quarter’s filings read Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
RHUMBLINE ADVISERS 94,984 SH275,447 dollarsLower by 97 Prior quarter: 95,081Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
Point72 Asset Management, L.P. 93,565 SH271,339 dollarsHigher by 52,493 Prior quarter: 41,072Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
Squarepoint Ops LLC Partly reported under another manager83,488 SH242,115 dollarsHigher by 16,410 Prior quarter: 67,078Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager70,237 SH203,688 dollarsHigher by 23,376 Prior quarter: 46,861Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
EntryPoint Capital, LLC 70,147 SH203,426 dollarsNot in the prior quarter’s filings read Open filing 0001992519-26-000009 Filed 2026-11-13 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager68,976 SH200,030 dollarsLower by 9,909 Prior quarter: 78,885Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 263,264 SH
  • GSA CAPITAL PARTNERS LLP 76,314 SH
  • Jump Financial, LLC 34,253 SH
  • AXQ CAPITAL, LP 22,880 SH
  • INTECH INVESTMENT MANAGEMENT LLC 17,290 SH
  • Indivisible Partners 10,000 SH
  • JONES FINANCIAL COMPANIES LLLP 38 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.001 par value per share7.67,644,072.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001738048-26-000100 Dispute this row
VHCP Co-Investment Holdings III, LLC Common Stock, $0.001 par value per share7.67,644,072.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001738048-26-000100 Dispute this row
Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.001 par value per share7.67,644,072.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001738048-26-000100 Dispute this row
VHCP Management III, LLC Common Stock, $0.001 par value per share7.67,644,072.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001738048-26-000100 Dispute this row
VHCP Management EG, LLC Common Stock, $0.001 par value per share7.67,644,072.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001738048-26-000100 Dispute this row
Nimish Shah Common Stock, $0.001 par value per share7.67,644,072.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001738048-26-000100 Dispute this row
Bong Y. Koh Common Stock, $0.001 par value per share7.67,644,072.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001738048-26-000100 Dispute this row
Deep Track Capital, LP Common Stock, par value $0.001 per share6.586,663,821.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-005081 Dispute this row
Deep Track Biotechnology Master Fund, Ltd. Common Stock, par value $0.001 per share5.665,737,941.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-005081 Dispute this row
David Kroin Common Stock, par value $0.001 per share6.586,663,821.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-005081 Dispute this row
Deep Track Special Opportunities Fund, LP. Common Stock, par value $0.001 per share0.91925,880.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-005081 Dispute this row
Coastlands Capital LP Common Stock, par value $0.001 per share9.9910,719,139.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-127412 Dispute this row
Coastlands Capital Partners LP Common Stock, par value $0.001 per share9.9910,719,139.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-127412 Dispute this row
Coastlands Capital GP LLC Common Stock, par value $0.001 per share9.9910,719,139.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-127412 Dispute this row
Coastlands Capital LLC Common Stock, par value $0.001 per share9.9910,719,139.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-127412 Dispute this row
Matthew D. Perry Common Stock, par value $0.001 per share9.9910,719,139.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-127412 Dispute this row
FMR LLC COMMON STOCK4.64,558,616.0009/30/2026 Filed 2026-10-07SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-002326 Dispute this row
Abigail P. Johnson COMMON STOCK4.64,558,616.0009/30/2026 Filed 2026-10-07SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-002326 Dispute this row
Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.001 par value per share5.65,555,047.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001738048-26-000071 Dispute this row
VHCP Co-Investment Holdings III, LLC Common Stock, $0.001 par value per share5.65,555,047.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001738048-26-000071 Dispute this row
Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.001 par value per share5.65,555,047.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001738048-26-000071 Dispute this row
VHCP Management III, LLC Common Stock, $0.001 par value per share5.65,555,047.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001738048-26-000071 Dispute this row
VHCP Management EG, LLC Common Stock, $0.001 par value per share5.65,555,047.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001738048-26-000071 Dispute this row
Nimish Shah Common Stock, $0.001 par value per share5.65,555,047.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001738048-26-000071 Dispute this row
Bong Y. Koh Common Stock, $0.001 par value per share5.65,555,047.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001738048-26-000071 Dispute this row
Perceptive Advisors LLC Common Stock, par value $0.001 per share8.18,085,00606/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-352651 Dispute this row
Joseph Edelman Common Stock, par value $0.001 per share8.18,085,00606/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-352651 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.001 per share8.18,085,00606/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-352651 Dispute this row
Deep Track Capital, LP Common Stock, par value $0.001 per share8.338,040,894.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-003487 Dispute this row
Deep Track Biotechnology Master Fund, Ltd. Common Stock, par value $0.001 per share7.186,923,680.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-003487 Dispute this row
David Kroin Common Stock, par value $0.001 per share8.338,040,894.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-003487 Dispute this row
Deep Track Special Opportunities Fund, LP. Common Stock, par value $0.001 per share1.161,117,214.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-003487 Dispute this row
BlackRock, Inc. Common Stock5.95,529,57306/30/2026 Filed 2026-07-30SCHEDULE 13GOpen filing 0002012383-26-003133 Dispute this row
Perceptive Advisors LLC Common Stock, par value $0.001 per share7.36,889,16303/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-226568 Dispute this row
Joseph Edelman Common Stock, par value $0.001 per share7.36,889,16303/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-226568 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.001 per share7.36,889,16303/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-226568 Dispute this row
Morgan Stanley Common Stock10.28,884,33802/28/2026 Filed 2026-03-06SCHEDULE 13G/AAmendment 1Open filing 0000895421-26-000094 Dispute this row
Morgan Stanley Investment Management Inc. Common Stock10.28,884,30402/28/2026 Filed 2026-03-06SCHEDULE 13G/AAmendment 1Open filing 0000895421-26-000094 Dispute this row
Inception Trust Common Stock5.24,518,23602/28/2026 Filed 2026-03-06SCHEDULE 13G/AAmendment 1Open filing 0000895421-26-000094 Dispute this row
Bain Capital Life Sciences Fund, L.P. Common Stock, par value $0.001 per share0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054779 Dispute this row
Bain Capital Life Sciences Fund II, L.P. Common Stock, par value $0.001 per share0.0764,19012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054779 Dispute this row
BCIP Life Sciences Associates, LP Common Stock, par value $0.001 per share0.017,81712/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054779 Dispute this row
BCLS II Investco, LP Common Stock, par value $0.001 per share0.8758,59812/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054779 Dispute this row
BCLS I Investco, LP Common Stock, par value $0.001 per share0.0989,63312/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054779 Dispute this row
BCLS II Equity Opportunities, LP Common Stock, par value $0.001 per share7.437,047,21612/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054779 Dispute this row
Trails Edge Capital Partners, LP Common Stock, par value $0.001 per share5.85,227,222.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001493152-26-007144 Dispute this row
Trails Edge Biotechnology Master Fund, LP Common Stock, par value $0.001 per share5.85,227,222.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001493152-26-007144 Dispute this row
Ortav Yehudai Common Stock, par value $0.001 per share5.85,227,222.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001493152-26-007144 Dispute this row
BIOTECHNOLOGY VALUE FUND L P Common Stock, par value $0.001 per share2.11,827,005.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-000476 Dispute this row
BVF I GP LLC Common Stock, par value $0.001 per share2.11,827,005.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-000476 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,708,462 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015124,844
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to X4 PHARMACEUTICALS, INC